Eva Martínez‐Moragón

1.1k total citations
49 papers, 727 citations indexed

About

Eva Martínez‐Moragón is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Eva Martínez‐Moragón has authored 49 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Physiology, 32 papers in Pulmonary and Respiratory Medicine and 9 papers in Immunology and Allergy. Recurrent topics in Eva Martínez‐Moragón's work include Asthma and respiratory diseases (38 papers), Respiratory and Cough-Related Research (29 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). Eva Martínez‐Moragón is often cited by papers focused on Asthma and respiratory diseases (38 papers), Respiratory and Cough-Related Research (29 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). Eva Martínez‐Moragón collaborates with scholars based in Spain, Australia and Chile. Eva Martínez‐Moragón's co-authors include M. Perpiñá, A. de Diego Damiá, Amparo Belloch, Estrella Fernández Fabrellas, Pere Casán, Rosario Menéndez, Ludovic Ferrer, César Picado, Carlos Rubio-Terrés and Joan Serra-Batllés and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Eva Martínez‐Moragón

47 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Martínez‐Moragón Spain 16 422 418 138 87 62 49 727
Wendy Fergusson New Zealand 18 527 1.2× 1.2k 2.8× 170 1.2× 69 0.8× 41 0.7× 22 1.4k
C. Villasante Spain 15 621 1.5× 912 2.2× 96 0.7× 37 0.4× 36 0.6× 50 1.1k
C. F. Robertson Australia 14 667 1.6× 786 1.9× 104 0.8× 54 0.6× 32 0.5× 20 1.1k
Watchara Boonsawat Thailand 16 915 2.2× 1.0k 2.4× 72 0.5× 48 0.6× 12 0.2× 58 1.3k
Cristina Gonçalves Alvim Brazil 12 264 0.6× 228 0.5× 45 0.3× 46 0.5× 9 0.1× 41 507
Cássio da Cunha Ibiapina Brazil 16 401 1.0× 315 0.8× 36 0.3× 146 1.7× 5 0.1× 57 746
Troy Turner Canada 9 49 0.1× 185 0.4× 273 2.0× 46 0.5× 115 1.9× 15 487
Reinier P. Akkermans Netherlands 16 267 0.6× 356 0.9× 75 0.5× 14 0.2× 19 0.3× 38 712
Herman Bueving Netherlands 15 224 0.5× 111 0.3× 186 1.3× 20 0.2× 24 0.4× 30 643

Countries citing papers authored by Eva Martínez‐Moragón

Since Specialization
Citations

This map shows the geographic impact of Eva Martínez‐Moragón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Martínez‐Moragón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Martínez‐Moragón more than expected).

Fields of papers citing papers by Eva Martínez‐Moragón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Martínez‐Moragón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Martínez‐Moragón. The network helps show where Eva Martínez‐Moragón may publish in the future.

Co-authorship network of co-authors of Eva Martínez‐Moragón

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Martínez‐Moragón. A scholar is included among the top collaborators of Eva Martínez‐Moragón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Martínez‐Moragón. Eva Martínez‐Moragón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González‐Barcala, Francisco Javier, Irina Bobolea, Javier Domínguez‐Ortega, et al.. (2024). Time is lung: higher preservation of lung function in severe asthma patients after earlier mepolizumab treatment. ERJ Open Research. 11(1). 211–2024. 1 indexed citations
2.
Arismendi, Ebymar, et al.. (2023). REDES Study: Mepolizumab Is Effective in Patients With Severe Asthma and Comorbid Nasal Polyps. Journal of Investigational Allergology and Clinical Immunology. 33(6). 476–479. 1 indexed citations
3.
Domingo, Christian, et al.. (2023). Potential impact of mepolizumab in stepping down anti-osteporotic treatment in corticosteroid-dependent asthma. Frontiers in Pharmacology. 14. 1183156–1183156. 2 indexed citations
4.
Puente‐Maestu, Luís, Ignacio Dávila, Santiago Quirce, et al.. (2023). Burden of refractory and unexplained chronic cough on patients’ lives: a cohort study. ERJ Open Research. 9(5). 425–2023. 5 indexed citations
5.
Vitale, Raffaele, et al.. (2023). Health-related quality of life and radiological and functional lung changes of patients with COVID-19 Pneumonia 3 and 10 months after discharge. BMC Pulmonary Medicine. 23(1). 231–231. 3 indexed citations
6.
Llano, Luis Pérez de, Vicente Plaza, José Antonio Gullón Blanco, et al.. (2022). The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma–COPD Overlap Syndrome. Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona). 6 indexed citations
7.
Perpiñá, M., et al.. (2021). Documento de consenso de expertos para el control del asma en personas mayores. Medicina Clínica. 159(1). 53.e1–53.e14.
8.
Llano, Luís Pérez de, Juan Luis García‐Rivero, Isabel Urrutia, et al.. (2018). A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy. The Journal of Allergy and Clinical Immunology In Practice. 7(4). 1214–1221.e3. 8 indexed citations
9.
Martínez‐Moragón, Eva, et al.. (2013). Factors affecting quality of life of asthma patients in Spain: The importance of patient education. Allergologia et Immunopathologia. 42(5). 476–484. 9 indexed citations
10.
Vennera, María del Carmen, Luis Pérez de Llano, Santiago Bardagí, et al.. (2012). Omalizumab Therapy in Severe Asthma: Experience from the Spanish Registry—Some New Approaches. Journal of Asthma. 49(4). 416–422. 64 indexed citations
11.
Martínez‐Moragón, Eva, et al.. (2009). Coste económico del paciente asmático en España (estudio AsmaCost). Archivos de Bronconeumología. 45(10). 481–486. 67 indexed citations
12.
Martínez‐Moragón, Eva, M. Perpiñá, & Amparo Belloch. (2006). Does Experience Influence Perception of Dyspnea?. Archivos de Bronconeumología. 42(4). 171–174. 5 indexed citations
13.
Martínez‐Moragón, Eva, et al.. (2005). Scientific Impact of the Asthma Awareness Year, 2003: Analysis of Publications in Archivos de Bronconeumología. Archivos de Bronconeumología. 41(12). 679–685. 1 indexed citations
14.
Martínez‐Moragón, Eva, M. Perpiñá, Amparo Belloch, & A. de Diego Damiá. (2005). Prevalence of Hyperventilation Syndrome in Patients Treated for Asthma in a Pulmonology Clinic. Archivos de Bronconeumología. 41(5). 267–271. 22 indexed citations
15.
Martínez‐Moragón, Eva, et al.. (2004). Community-Acquired Pneumonia Among the Elderly: Differences Between Patients Living at Home and in Nursing Homes. Archivos de Bronconeumología. 40(12). 547–552. 26 indexed citations
16.
Martínez‐Moragón, Eva, Vicente Plaza, José Serrano, et al.. (2004). Near-fatal asthma related to menstruation. Journal of Allergy and Clinical Immunology. 113(2). 242–244. 47 indexed citations
17.
Martínez‐Moragón, Eva, et al.. (2003). Percepción de la disnea durante la broncoconstricción aguda en los pacientes con asma. Archivos de Bronconeumología. 39(2). 67–73. 33 indexed citations
18.
Martínez‐Moragón, Eva, et al.. (2003). Determinants of Dyspnea in Patients with Different Grades of Stable Asthma. Journal of Asthma. 40(4). 375–382. 43 indexed citations
19.
Belloch, Amparo, et al.. (2003). Gender Differences in Health‐Related Quality of Life Among Patients with Asthma. Journal of Asthma. 40(8). 945–953. 37 indexed citations
20.
Martínez‐Moragón, Eva, et al.. (2002). Percepción de mejoría en los pacientes con asma. Archivos de Bronconeumología. 38(10). 468–472. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Fergusson Breakdown of academic impact, for papers by C. Villasante Breakdown of academic impact, for papers by C. F. Robertson Breakdown of academic impact, for papers by Watchara Boonsawat Breakdown of academic impact, for papers by Cristina Gonçalves Alvim Breakdown of academic impact, for papers by Cássio da Cunha Ibiapina Breakdown of academic impact, for papers by Troy Turner Breakdown of academic impact, for papers by Reinier P. Akkermans Breakdown of academic impact, for papers by Herman Bueving
Rankless by CCL
2026